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Objective: To compare the reproductive outcomes between the transfer of cleavage-stage embryos and
blastocysts in two different age groups of patients. The reproductive capacity of women decreases by age.
This decrease in capacity is directly related to a lower ovarian reserve and errors in the meiotic spindle of
the oocyte, which increase chromosomal abnormalities and the formation of aneuploidy embryos with
lower chances of implantation.
Materials and Methods: A total of 1400 intracytoplasmic sperm injection cycles were analyzed. The study
patients were divided into two age groups [aged < 36 years (Group I) and aged S 36 years (Group II)].
The groups were subdivided according to the day of embryo transfer (ET)dDay 3 (ET3) and Day 5 (ET5).
Results: In both age groups, transfer of blastocysts resulted in a higher clinical pregnancy rate and de-
liveries. An increased twin birth rate was observed in patients who were younger than 36 years on both
transfer days compared with those who were older than 36 years of age. There was an elevated per-
centage of newborn males on ET5 in both age groups. Monozygotic twinning (MZT) rate was observed
only among younger patients (<36 years of age), speciﬁcally on ET5 compared with ET3. There was no
signiﬁcant difference in the mean birth weight of singleton and twins between the ET3 and ET5 sub-
groups in the younger group of patients except for the triplets who were signiﬁcantly heavier in the ET5
group compared with the older group (S36 years of age) where signiﬁcant difference was found only on
the mean birth weight of singleton.
Conclusion: The study suggests that if a blastocyst can be obtained in patients of advanced age (S36
years), it improves their baby take-home rates. Younger patients (aged < 36 years) should undergo
elective single blastocyst transfers to reduce multiple pregnancy rates.
Copyright © 2015, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All
rights reserved.Introduction
The prevalence of infertility is increasing, but its rate varies
demographically and regionally [1]. This could be attributed to the
fact that couples prioritize lifestyle and career over the creation of a
family [2]. As the options for treatments of infertility keep
increasing and the outcomes of such treatments are improving,Remedika, 16ta Makedonska
ka).
bstetrics & Gynecology. Publishedcouples delay their treatments [3]. However, there is a very strong
relationship between age, decreased ovarian reserve, and errors in
the meiotic spindle, which increase chromosomal abnormalities in
the oocytes and the formation of aneuploid embryos with very low
implantation rates [4,5]. Age has a highly negative impact on the
pregnancy chances and assisted reproductive technologies cannot
compensate for basic physiological preconditions of reproductive
senescence [2]. Although menopause indicates the end of women's
fertility, the decline actually begins many years before menopause
[6]. Therefore, women older than 35 years of age should be referred
for an infertility work-up after 6 months of unsuccessful attempts
to conceive [3]. A number of different evaluations and treatmentby Elsevier Taiwan LLC. All rights reserved.
Table 1
Demographics and cycle characteristics of female patients younger than 36 years of
age (N ¼ 958).
Parameter ET3 ET5
Age (y) 30.0 ± 3.3 29.4 ± 3.1
Basal FSH (IU/L) 7.2 ± 2.2 7.0 ± 2.3
Estradiol on the day of hCG injection (pg/mL) 1509 ± 666 1620 ± 918*
Retrieved number of oocytes/cycle 13.1 ± 6.1 13.9 ± 7.3
Number of mature oocytes/cycle 9.4 ± 5.5 10.8 ± 6.4
Fertilization rate (%) 70 ± 0.19 69 ± 0.2
No. of ICSI cycles embryo transfer 654 304
No. of embryos transferred/cycle 2.65 ± 0.7 2.6 ± 0.6
Embryos transferred 1777 825
Data are presented as n (%) or mean ± standard deviation.
* p < 0.05 was considered statistically signiﬁcant.
ET ¼ embryo transfer; FSH ¼ follicle-stimulating hormone; hCG ¼ human chorionic
gonadotropin; ICSI ¼ intracytoplasmic sperm injection.
Table 2
Demographics and cycle characteristics of female patients aged 36 years or older
(N ¼ 442).
Parameter ET3 ET5
Age (y) 38.5 ± 2.11 38.8 ± 2.55
Basal FSH (IU/L) 7.4 ± 2.2 7.6 ± 2.2
Estradiol on the day of hCG injection (pg/mL) 1636 ± 851 1508 ± 652*
Retrieved number of oocytes/cycle 12.0 ± 6.3 12.3 ± 6.2
Number of mature oocytes/cycle 8.8 ± 5.1 9.8 ± 5.3
Fertilization rate (%) 70 ± 0.19 69 ± 0.2
No. of ICSI cycles embryo transfer 275 167
No. of embryos transferred/cycle 2.6 ± 0.65 2.5 ± 0.63
Embryos transferred 718 393
Data are presented as n (%) or mean± standard deviation.
* p < 0.05 was considered statistically signiﬁcant.
ET ¼ embryo transfer; FSH ¼ follicle-stimulating hormone; hCG ¼ human chorionic
gonadotropin; ICSI ¼ intracytoplasmic sperm injection.
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fertilities that improve the baby take-home rates [7].
A better understanding of the mechanisms involved in the
development of human embryos has led to the production of cul-
ture media that support extended cultivation of embryos (up to the
blastocyst stage) [8,9]. It is thought that the transfer of high-quality
blastocysts will result in higher implantation rates [10], give a
better synchronization between the blastocyst and the endome-
trium [11], and generate higher pregnancy and live birth rates in
comparison to transfer of cleavage-stage embryos [10]. However, it
seems that the cumulative clinical pregnancy rate for cleavage-
stage embryos is higher than that for blastocysts [12].
Besides, there are several potential limitations to transfer of
blastocysts such as higher cancellation risks [13], lower freezing
rates [14], and a higher incidence of monozygotic twinning (MZT)
rates [15]. There is also a risk of premature deliveries of babies with
lower birth weights [16], generation of epigenetic mutations in
offspring [17], and altered sex ratios [11].
The aim of this study was to compare the reproductive out-
comes between cleavage-stage embryos and blastocyst transfers in
two different age groups of patients. The study results should
provide valuable information for making better decisions about
selection of appropriate day of embryo transfer (ET; ET3 vs. ET5) in
these patients (aged < 36 years vs. agedS 36 years).
Materials and methods
Patient selection criteria
Тhis retrospective study was approved by the Clinical Research
and Research Ethics Committees of the General Hospital-Remedika,
Skopje, Macedonia. The study encompassed the period from
February 2008 to December 2013, during which 3049 cycles were
performed. The exclusion criteria were donation (sperm, oocyte, or
embryos) and spontaneous cycles; frozen/thawed ETs; protocols in
which antagonist andmicroﬂare were used; patients with an antral
follicle count lower than ﬁve follicles and basal follicle-stimulating
hormone (bFSH) levels greater than 11 mIU/mL when less than ﬁve
metaphase II oocytes were retrieved; and in those cycles where the
ET was cancelled. After applying the aforementioned exclusion
criteria, 1400 cycles were ﬁnally included in the study.
Study group
The patients were divided into two groups according to their
age: younger than 36 years of age (Group I) and 36 years of age or
older (Group II). Each group was further divided in two subgroups
according to the day of ET: Day 3 (ET3) and Day 5 (ET5). If the pa-
tient had more than four excellent or good embryos according to
selected criteria on Day 3 or had a previous history of implantation
failure, the embryos were selected for blastocyst transfer.
Both groups were comparable in terms of average female age,
bFSH and E2 levels on Day 3, dose of exogenous gonadotropins,
yield of metaphase II oocytes, fertilization rates, and grade of em-
bryos transferred in both age groups (Tables 1 and 2).
Male infertility factor (oligozoospermia, asthenozoospermia,
teratozoospermia, or combined) contributed to 70% of infertility in
Group I and 73% in Group II. Consequently, intracytoplasmic sperm
injection (ICSI)was chosen as the fertilizationmethod for all patients.
Ovarian stimulation
A long stimulation protocol was used in all patients. Down-
regulation was initiated with buserelin acetate (Suprefact, Sanoﬁ
Aventis, Kalithea, Athens, Greece) during the mid-luteal phase.Injections of recombinant follitropin beta (Puregon, N.V. Oregon,
Os, The Netherlands) were initiated on the 3rd day of menstrual
cycle. The doses were adjusted to the patient's age and the number
of preantral follicles in the ovary. When at least two follicles
measuring over 18mmwere visible in the ovaries, human chorionic
gonadotropin (hCG, 10,000 IU; Pregnyl, N.V. Organon, Os, The
Netherlands) was injected for triggering maturation of oocytes.
Egg collection routines and culture technique
Transvaginal ultrasound-guided oocyte retrieval was performed
under short intravenous anesthesia (Propofol-Lipuro 1%, Braun
Melsungen AG, Melsungen, Germany). Thirty-six to thirty-seven
hours after the hCG injection, the cumuluseoophorous complexes
(COCs) were aspirated using a single-lumen aspiration needle
(17GA/30 cm, Cook Medical, Eight Mile Plains, Brisbane, Australia)
at an aspiration pressure of 80e100mmHg. All retrieved COCs were
washed free from the follicular ﬂuid in Quinn's Advantage medium
containing HEPES (SAGE, CooperSurgical, Trumbull, CT, USA). All
oocytes and embryos were cultured in preincubated Quinn's
Advantage sequential media under mineral oil (SAGE, Cooper-
Surgical, Trumbull, CT, USA).
Denudation of oocytes and ICSI techniques
Four hours after egg collection, the COCs were transferred into
a 100-mL drop of hyaluronidase solution (80 IU/mL hyaluronidase,
SAGE, CooperSurgical, Trumbull, CT, USA) and repeatedly aspirated
through a Pasteur pipette for 20e30 seconds. Mechanical
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dium (50 mL droplets) by repeated aspiration into stripper tips
(Flexipet, Cook Medical, Bloomington, IN, USA).
All metaphase II oocytes were injected using a 35-degree angled
ICSI pipette (Cook Medical, Bloomington, IN, USA). The oocytes
were considered normally fertilized when they had two pronuclei
and two polar bodies 16e18 hours after ICSI. Embryos were clas-
siﬁed according to the scoring system of Hardarson et al [18].Sperm preparation techniques
The semen samples were obtained by masturbation after 2e5
days of abstinence. Semen analysis was performed 30 minutes
following liquefaction [19] followed by semen sample preparation
by density gradient centrifugation using 90% and 50% PureCeption
(SAGE, Trumbull, CT, USA).Embryo transfer technique
On Day 3, all embryos were transferred into Quinn's blastocyst
medium and the embryos were selected either for transfer on the
same day or for culture and transfer on Day 5. Evaluation of embryo
quality on Day 3 was based on blastomeres number, fragmentation
rate, multinucleation, and early compaction. The selection criteria
of Day 3 embryos were early cleavage on Day 1, four cells on Day 2,
and eight cells or early compaction on Day 3, with minimal frag-
mentation and no multinucleation. After applying the selection
criteria, transfer was only performed using Grade I (excellent
quality) embryos (with at least eight blastomeres on Day 3, of equal
size, with <10% of fragmentation, and no multinucleation) and
Grade II (good quality) embryos (6e10 blastomeres, equal or
moderate in size, with <15e20% of fragmentation, and no multi-
nucleation). Grade III (fair quality) and Grade IV (bad quality) em-
bryos were not transferred.
All transfers were performed under abdominal ultrasonography
guidance using a soft embryo catheter (K-SOFT 5000, CookMedical,
Eight Mile Plains, Brisbane, Australia). The number of embryos for
transfer varied from one to three, considering the age and previous
history of the patient. The remaining surplus high-quality embryos
were cryopreserved with vitriﬁcation (SAGE Vitriﬁcation kit, SAGE
Trumbulll, IN, USA). Intravaginally administrated progesterone
(Crinone 8%, Merck Serono, Darmstadt, Germany) was used as the
luteal phase support.Statistical analysis and deﬁnition
A database for 1400 samples was generated. Statistical analysis
included descriptive statistics and Chi-square test using SPSS soft-
ware 13.0 (SPSS, Inc., Chicago, IL, USA). Differences were considered
signiﬁcant when p values were less than 0.05.
Pregnancy test was considered positive when positive serum
hCG levels (>5.3 mIU/ml) were detected 14 days after ET. A clinical
pregnancy was considered established when at least one visible sac
with heart beating was detected by transvaginal ultrasonography 5
weeks after ET. A biochemical pregnancy was deﬁned as a preg-
nancy without an intrauterine sac. Spontaneous abortion until 12
gestation weeks was registered as having empty gestation sac
(blighted ovum) or fetal demise detected by transvaginal ultra-
sound. Second-trimester abortion was deﬁned as the case in which
the fetus was lost between gestation weeks 13 and 26. Preterm
deliveries were deﬁned as babies born alive before 37 weeks of
pregnancy.Results
Outcomes of ICSI in Group I
The outcome of the ICSI cycles in the younger age group (patient
age < 36 years; N ¼ 958) is shown in Table 3.
There was neither signiﬁcant difference in the fertilization rates
nor in the mean numbers of embryos transferred on the 3rd day
(2.65 ± 0.7) or 5th day (2.6 ± 0.6; Table 1).
The quality of the transferred embryos and the pregnancy rates
[positive beta-hCG/ET, 63% (415/654) and 62.5% (190/304) for ET3
and ET5, respectively] were not signiﬁcantly different between the
two subgroups.
In addition, the clinical pregnancy rate/ET was not signiﬁcantly
higher on Day 5 (57%; 172/304) compared with Day 3 (55%; 360/
654); however, there was a difference in the implantation rates
between ET on Day 3 (32.6%) and Day 5 (38.9%).
There was also a signiﬁcantly higher biochemical pregnancy
rate, missed abortion rate (until the 12th gestation week), and
second-trimester abortion rate (12the26th gestation week) after ET
on Day 3 in this age group of patients.
For patients in the ET3 subgroup, 447 babies were born from
305 deliveries, consisting of 250 (56%) females and 197 (44%)males,
with a multiple delivery frequency of 43% (132/305), 40% (122/305)
twins, and 3.3% (10/305) triplets (Table 3). In the ET5 subgroup, 234
babies were born with a statistical signiﬁcance between males
(57%, 133/234) and females (43%, 101/234; Table 3).
There was no signiﬁcant difference in the mean birth weight of
singleton and twins between the ET3 and ET5 subgroups, except for
the triplets who were signiﬁcantly heavier in the ET5 subgroup
(Table 5). A statistical difference in only height was found in twins
between the two subgroups.
In this group, there was a signiﬁcant difference in the percent-
age of monozygotic twins [0.5% (2/360) for ET3 vs. 2.9% (5/172) for
ET5].Outcomes of ICSI in Group II
The outcome of the ICSI cycles for the patients (aged 36 years or
older) in Group II (N ¼ 442) is presented in Table 4. The fertilization
rates were 70% and 69% for the ET3 and ET5 subgroups, respectively
(Table 2). A beta-hCG test was positive in 50% of patients (12%
biochemical) in the ET3 subgroup. Thirty-eight percentages (106/
275) of these patients had a viable fetal heartbeat and 6.9% (19/275)
had a miscarriage or had their pregnancy aborted therapeutically.
The ﬁnal ongoing pregnancy rate was 31% (84/275) with 100
newborn babies.
In this group, 55% (92/167) of patients in the ET5 subgroup were
positive for beta-hCG. There was no signiﬁcant difference in the
implantation rates between ET3 and ET5, but the clinical pregnancy
rate (48%, 80/167) was signiﬁcantly higher in the ET5 subgroup
than that in the ET3 subgroup. There was a signiﬁcant difference in
the percentage of deliveries between ET3 and ET5 (31% and 43%,
respectively).
There was a signiﬁcant difference in multiple birth rates
(singleton and twins) between transfer of cleavage-stage embryos
and blastocysts. The sex ratio of the delivered babies was 53%
versus 44% for females and 47% versus 56% male in the ET3 and ET5
subgroups, respectively.
There was a signiﬁcant difference in the mean birth weight of
singletons, but not in twins between the ET3 and ET5 subgroups
(Table 6). Statistical differencewas found only in the height of twins
(p < 0.05) between these two subgroups. However, statistical
analysis for these two parameters (height and weight) could not be
Table 4
Pregnancy outcomes in intracytoplasmic sperm injection cycles for female patients 36 years or older (N ¼ 442).
Parameter ET3 ET5
Positive beta-hCG rate (%) 50 (138/275) 55 (92/167) *
_Implantation rate (%) 30 (201/673) 32 (125/393)
Biochemical pregnancy (%) 12 (32/275) 7 (12/167) *
Clinical pregnancy rate (%) 38 (106/275) 48 (80/167) *
Missed abortion (until 12 gestation weeks, %) 5.4 (15/275) 4.0 (7/167) *
Second-trimester abortion (12e26 gestation weeks, %) 1.4 (4/275) 1.0 (2/167)
Deliveries (%) 31 (84/275) 43 (71/167) *
- Singleton (%) 80 (67/83) 72 (51/71) *
- Twins (%) 19 (16/83) 25 (18/71) *
- Triplets (%) 0 1.5 (1/71) *
- Perinatal mortality (%) 1 (1/84) 1.5 (1/71) *
Monozygotic twins (%) 0 0
Total preterm deliveries (%) 18 (15/84) 18 (13/71)
- Preterm deliveries singleton (%) 47 (7/15) 0
Newborn females (%) 53 (53/100) 44 (40/91) *
Newborn males (%) 47 (47/100) 56 (51/91) *
Data are presented as n (%) or mean± standard deviation.
* p < 0.05 was considered statistically signiﬁcant.
ET ¼ embryo transfer; hCG ¼ human chorionic gonadotropin.
Table 3
Pregnancy outcomes in intracytoplasmic sperm injection cycles for female patients younger than 36 years (N ¼ 958).
Parameter ET3 ET5
Positive beta-hCG rate (%) 63 (415/654) 62.5 (190/304)
_Implantation rate (%) 32.6 (581/1777) 38.9 (321/825) *
Biochemical pregnancy (%) 8.0 (55/654) 6.3 (18/304) *
Clinical pregnancy rate (%) 55 (360/654) 57 (172/304)
Missed abortion (until 12 gestation weeks, %) 4.1 (27/654) 2.0 (6/304) *
Second-trimester abortion (12e26 gestation weeks, %) 4.2 (28/654) 3.0 (9/304) *
Deliveries (%) 46.6 (305/654) 51.6 (157/304) *
Singleton (%) 56.7 (173/305) 56.0 (88/157)
Twins (%) 40 (122/305) 39 (61/157)
Triplets (%) 3.3 (10/305) 5.0 (8/157) *
Monozygotic twins (%) 0.5 (2/360) 2.9 (5/172) *
Total preterm deliveries (%) 23 (71/305) 25 (40/157)
Preterm deliveries singleton (%) 19.7 (14/71) 10.0 (4/40) *
Newborn females (%) 56 (250/447) 43 (101/234) *
Newborn males (%) 44 (197/447) 57 (133/234) *
Data are presented as n (%) or mean± standard deviation.
* p < 0.05 was considered statistically signiﬁcant.
ET ¼ embryo transfer; hCG ¼ human chorionic gonadotropin.
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subgroup. Group II had no monozygotic twins.Discussion
One of the most important factors affecting in vitro fertilization
outcomes is maternal age, as increasing age is associated with
reduced oocyte quality and high chromosomal instability [20]. It is
still unclear whether advanced female age has an opposing effect
on blastocyst formation.
In this study, the highest clinical pregnancy rates were found in
women undergoing ET on Day 5 (57% in Group I and 48% in GroupTable 5
Mean birthweight and height of singleton, twins, and triplet newborns resulting
from ET3 and ET5 in female patients younger than 36 years.
Deliveries Weight (ET3/ET5) Height (ET3/ET5)
Singleton 3189 ± 457/3211 ± 417 49.9 ± 1.6/50.6 ± 0.5
Twins 2263 ± 408/2474 ± 376 46.6 ± 1.9/49.6 ± 1.0 *
Triplets 1863 ± 164.7/2252 ± 474 * 43.7 ± 0.6/43.7 ± 3.3
Data are presented as weight (g) or height (cm) with mean± standard deviation.
* p < 0.05 was considered statistically signiﬁcant.II). However, in the higher age group (age of patients S36 years;
Group II), there was a signiﬁcant decrease in the clinical pregnancy
and delivery rates in comparison to those of the younger age group
(age of patients < 36; Group I). This suggests that women of
advanced age, despite having low basal FSH level (<10 mIU/mL)
have a lower chance of establishing a pregnancy via assisted
reproductive technology. This decrease in fertility might primarily
be due to oocyte senescence rather than due to poor endometrial
receptivity, because older women produce less oocytes and have
lower implantation rates, which suggests the lower response of the
follicles to exogenous hormones and the retrieval of a lower
number of high-quality oocytes [21]. Older women may haveTable 6
Mean birthweight and height of singleton, twins, and triplet newborns resulting
from ET3 and ET5 in female patients aged 36 years or older.
Deliveries Weight (ET3/ET5) Height (ET3/ET5)
Singleton 2872 ± 751/3467 ± 373 * 49.2 ± 3.3/50 ± 1.4
Twins 2555 ± 348/2697 ± 312 48.1 ± 2.4/48.5 ± 0.7 *
Triplets 0/1893 ± 347 0/42.6 ± 5.0
Data are presented as weight (g) or height (cm) with mean± standard deviation.
* p < 0.05 was considered statistically signiﬁcant.
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responsible for trophectoderm function and maintenance of the
blastocoel [22].
Despite the adverse effects of multiple pregnancies, many clinics
still transfer more than one embryo to increase the chances of
establishing a pregnancy [23]. In this study, we found very high
multiple pregnancy rates in patients aged less than 36 years (Group
I) with a twinning rate of 40% in the ET3 subgroup and 39% in the
ET5 subgroup. This is in contrast to the much lower twinning rate
found in the older age group (patients aged S 36 years), where
twinning rates of 19% and 25% were reported in the ET3 and ET5
subgroups.
We found that transfer of Day 3 embryos resulted in higher
miscarriage rate in comparison to transfer of Day 5 embryos be-
tween the two age groups (Groups I and II). These observations are
in linewith a previous report [24], which indicated that the transfer
of blastocysts generates higher pregnancy rates. These observations
suggest that blastocyst selection is more reassuring in terms of
pregnancy achievement, because the selection is made through a
cohort of cleavage-stage embryos that have already survived the
process of initial selection. These results also demonstrate the
important role of uterine receptivity in successful implantation.
In both age groups, the transfer of blastocysts resulted in a
higher percentage of male babies (57% and 56% for Group I and
Group II, respectively), which might depend on the selection of fast
developing expanded blastocysts for ET [25]. In addition, it is
thought that in vitro culture induces a precocious inactivation of the
X-chromosome and that ICSI decreases the number of trophecto-
derm cells in female blastocysts, thereby increasing the risk of early
postimplantation failure [26]. The genes controlling glucose uptake
and metabolism (glucose-6-phosphate dehydrogenase) and anti-
oxidants (hypoxanthine phosphoribosyl transferase) are located on
the X chromosome. The activities of these genes and potentially
certain enzymes, might delay the development of female embryos
[27]. Orvos et al [28] found a maternal and paternal age effect on
the sex ratio in ICSI cycles [28]; however, no such correlation was
found in our study. In addition, it has been suggested that the
source of protein in the selected culture media might alter the sex
ratio after ICSI [29].
Blastocyst transfers also seem to increase the MZT rate. The
exact pathogenesis for embryo splitting is still unknown, but
multiple factors seem to affect the outcome such as maternal age,
micromanipulation of the zona pellucida (ICSI and assisted hatch-
ing), prolonged embryo culture, and altered in vitro culture condi-
tion [30,31]. In our study, ICSI was performed in all patients, but
assisted hatching was not done. Despite this, the incidence of MZT
wasmuch higher on Day 5 (2.9%) comparedwith Day 3 (0.5%). It has
also been suggested that high MZT rates relate to longer culture
periods [32,33] and components within the culture media, such as
high levels of glucose [34] and low levels of calcium, which increase
the division in the inner cell mass and destabilize the intracellular
bonds between the cells [35]. In addition, the inﬂuence of growth
factors such as insulin receptors (insulin-like growth factors 1 and
2) may induce changes in signaling, cytoplasmic shifting, and po-
larity changes in the embryo, which may increase MZT [36,37].
Previous reports have also suggested that advanced maternal age
increases the MZT rate as a result of a gradual decrease of the
average thickness of the zona pellucida altering the normal
hatching process [35]; however, Knopman et al [38] only found a
relationship between the age of female patient (<35 years) and
MZT.
There were also no signiﬁcant differences in the mean birth
weights if embryos were transferred on Day 3 (3189 ± 457 g) or Day
5 (3211 ± 417 g) in younger patients (age < 36 years), which was
also found in singleton births after blastocyst transfers [39].However the age of the patients was not documented in the latter
study [39]. The mean birth weight in the older age group in our
study was signiﬁcantly higher for ETs on Day 5 (3467 ± 373 g) in
comparison to that for ETs on Day 3 (2872 ± 751 g).
Interestingly, our results also show a statistical difference in the
height of twins in both age groups, with infants born after blasto-
cyst transfer being taller (Tables 5 and 6).
We did not ﬁnd statistical signiﬁcance in the total preterm de-
liveries between ET3 and ET5 in both age groups; however, a sta-
tistical difference was found in the preterm deliveries of the
singletons, with the highest rate achieved for ET3 in both age
groups. In our study the number of infants born after blastocyst
transfer is too small to evaluate rare outcomes, when compared
with data presented in meta analysis and systematic reviews [40].
We will continue to follow up the outcomes of neonates for future
consideration of the background risk of neonatal and obstetrics
complications.
In summary, it seems that if a blastocyst can be obtained in
patients of advanced age (S36 years), it improves their baby take-
home rates (Table 4). In younger patients, we suggest that an
elective single blastocyst transfer should be performed to reduce
the high multiple pregnancy rates.
Finally, the retrospective nature of the study may pose certain
limitations to our study. The possibility of bias was reduced such
that we isolated the effect of fertilization rate on implantation rate.
Furthermore, this study did not investigate whether the sperm
quality signiﬁcantly inﬂuences the outcomes although only ICSI
cases were included.
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